Effect of tolcapone on plasma and striatal apomorphine disposition in rats

NeuroReport

Volumn 8, Issue 4, 1997, Pages 877-880

  Coudoré, François ^b   Durif, Franck ^a   Duroux, Eliane ^b   Eschalier, Alain ^b   Fialip, Joseph ^b  

^a Hopital Fontmaure   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Apomorphine; Kinetics; Parkinson's disease; Tolcapone

Indexed keywords

APOMORPHINE; TOLCAPONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METABOLISM; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030939067     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199703030-00012     Document Type: Article

References (24)

1. Schwab RS, Amador LV and Lettvin JY. Trans Am Neurol Assoc 76, 251-253 (1951).
2. Stibe CMH, Kempster PA, Lees AJ et al. Lancet 9, 403-406 (1990).
3. Pollak P, Champay AS, Gajo JM et al. Rev Neurol 146, 116-122 (1990).
4. Deffond D, Durif F and Tournilhac M. J Neurol Neurosurg Psychiatry 56, 101-103 (1993).
5. Hughes AJ, Bishop S, Kleedorfer B et al. Mov Disorders 8, 168-170 (1993).
6. Gancher ST, Woodward WR, Boucher B et al. Ann Neurol 26, 232-238 (1989).
7. Nicolle E, Pollak P, Serre-Debeauvais F et al. Fund Clin Pharmacol 7, 245-252 (1993).
8. Blanchi G and Landi M. J Chromatogr 338, 230-235 (1985).
9. Blanchi G, Landi M and Garattini S. Eur J Pharmacol 131, 229-236 (1986).
10. Di Chiara G and Gessa GL. Adv Pharmacol Chemother 15, 87-160 (1978).
11. Kaul PN, Brochmann-Hanssen E and Way EL. J Pharm Sci 50, 248-251 (1961).
12. Kaul PN, Brochmann-Hanssen E and Way EL. J Pharm Sci 50, 840-842 (1961).
13. Kaul PN and Conway MW. J Pharm Sci 60, 93-95 (1971).
14. White HL and McKenzie GM. Pharmacologist 13, 313-315 (1971).
15. Cannon JG, Smith RV, Modiri A et al. J Med Chem 15, 273-276 (1972).
16. McKenzie GM and White HL. Biochem Pharmacol 22, 2329-2336 (1973).
17. Missala K. Lal S and Sourkes TL. Eur J Pharmacol 22, 54-58 (1973).
18. Gibaldi M and Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1982.
19. Karol M. J Pharmacokinet Biopharm 11, 179-181 (1990).
20. Campbell A, Kula NS, Jeppsson B et al. Eur J Pharmacol 67, 139-142 (1980).
21. Bredberg E and Paalzow LK. Pharm Res 7, 318-324 (1990).
22. Burkman AM, Notari RE and Ken Van Tyle W. J Pharm Pharmacol 26, 493-507 (1974).
23. Smith RV and Sood SP. J Pharm Sci 60, 1654-1658 (1971).
24. Zürcher G, Dingemanse J and Da Prada M. Adv Neurol 60, 641-647 (1993).